Xencor Inc (XNCR)
23.60
+0.42
(+1.81%)
USD |
NASDAQ |
Nov 08, 16:00
23.60
0.00 (0.00%)
After-Hours: 20:00
Xencor Revenue (Annual): 168.34M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 168.34M |
| December 31, 2022 | 164.58M |
| December 31, 2021 | 275.11M |
| December 31, 2020 | 122.69M |
| December 31, 2019 | 156.70M |
| December 31, 2018 | 40.60M |
| December 31, 2017 | 46.15M |
| Date | Value |
|---|---|
| December 31, 2016 | 109.02M |
| December 31, 2015 | 27.76M |
| December 31, 2014 | 9.52M |
| December 31, 2013 | 10.17M |
| December 31, 2012 | 9.524M |
| December 31, 2011 | 6.849M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
122.69M
Minimum
2020
275.11M
Maximum
2021
177.48M
Average
164.58M
Median
2022
Revenue (Annual) Benchmarks
| Biogen Inc | 9.836B |
| Dynavax Technologies Corp | 232.28M |
| SINTX Technologies Inc | 1.226M |
| Fulcrum Therapeutics Inc | 2.805M |
| Moderna Inc | 6.754B |